Search Results 41-50 of 34819 for chemoprevention
May have received TAM or raloxifene for purposes of chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (including previous ...
This study shows the need for further investment in evaluating the use of erlotinib and other chemoprevention therapies for cancer prevention in patients with ...
Related. Breast cancer chemoprevention · Breast Cancer Education Tool · Breast cancer staging · Breast cancer types · Breast self-examination · Common questions ...
Tue, Jul 22, 2025. See more discussions. Related. Breast cancer chemoprevention · Breast Cancer Education Tool · Breast cancer staging · Breast cancer types ...
Patients who received tamoxifen or raloxifene for purposes of chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (including ...
NOTE: prior use of tamoxifen for chemoprevention is allowed but must be discontinued at study entry; similarly, prior raloxifene use is allowed but must be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.